Read NOVARTIS PHARMACEUTICALS CORP. v. ABBOTT LABS., 03-1367, -1393

In a pharmaceutical patent dispute over a drug that helps prevent organ rejection in transplant patients, the court reversed on a claim construction issue, but affirmed a JMOL of non-infringement for the defendants.

Appellate Information

• Decided 07/08/2004
• Published 07/08/2004

Judges

• Before BRYSON, GAJARSA, and PROST, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellant:
  
• Robert L. Baechtold,Fitzpatrick, Cella, Harper & Scinto, of New York, NY, argued for plaintiffs-appellants.   With him on the brief were Nicholas N. Kallas, Stevan J. Bosses, and Diego Scambia.


• For Appellees:
  
• Jeffrey I. Weinberger, Munger, Tolles & Olson LLP, of Los Angeles, CA, argued for defendant-cross appellant.   With him on the brief were Ted G. Dane and Andrea Weiss Jeffries.